Prediction of treatment effect perception in cosmetics using machine learning. Issue 1 (2nd January 2021)

• Record Type: Journal Article
• Authors: Salah, Samir; Colomb, Loic; Benize, Amelie-Marie; Cornillon, Celine; Shaiek, Ayet; Charbit, John; Schritz, Anna
• Is Part Of: Journal of biopharmaceutical statistics. Volume 31:Issue 1(2021)
• Page Start: 55
• Page End: 62
• Publication Date: 2021-01-02
• Subjects: Cosmetics -- treatment effect perception -- clinical evaluation -- claim substantiation -- statistics -- discrete choice modelling -- machine learning; Pharmacy -- Statistical methods -- Periodicals; Drugs -- Testing -- Statistical methods -- Periodicals; Biometry -- Periodicals; Biopharmaceutics -- Periodicals; Pharmacokinetics -- Periodicals; 615.19
• DOI: 10.1080/10543406.2020.1792479
• Languages: English
• ISSNs: 1054-3406

Abstract

ABSTRACT: Perception of treatment effect (TE) in cosmetics is multifaceted and influenced by multiple parameters that need to be considered simultaneously when evaluating TE. Here we provide a global approach to predicting TE perception using Random Forest (RF) classifier. Data from three randomized double-blind clinical studies with a total of 50 subjects were used. Different products were applied to each facial cheek of subjects at each visit, and post-application photographs were taken. Nine primary endpoints relating to skin pores were assessed by a specific image analysis algorithm. Twenty judges evaluated the relative pore visibility in all possible pairs of cheek photographs. RF was used to construct a prediction model for TE perception based on the primary endpoints and judge's evaluation. Intra-study product ranking was done using the Bradley-Terry model on mean judges' predicted preference. RF demonstrated overall good accuracy in predicting TE perception. Applying RF technique not only addresses issues of multiplicity, nonlinearity and interactions between multiple criteria but also focuses decision-making on one discrete parameter thereby simplifying interpretability and allowing for more consumer-centered claim substantiation in clinical trials. Abbreviations : RF: Random Forest classifier; FDA: The US Food and Drug Agency; ID: Identifier; MCID: Minimal clinical important difference; Param: Parameter; PGIC: Patients' Global Impression of Change; TE: Treatment effect; TRT: Treatment